Veterinary Molecular Diagnostics Market PPT: Overview, Dynamics, Trends, Segmentation, Application and Forecast to 2032

imarc123 33 views 13 slides May 01, 2024
Slide 1
Slide 1 of 13
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13

About This Presentation

The global veterinary molecular diagnostics market size reached US$ 690.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,391.9 Million by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032.

More Info:- https://www.imarcgroup.com/veterinary-molecular-diag...


Slide Content

Global Veterinary Molecular Diagnostics Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved

About IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Highlight and Description According to the latest report by IMARC Group, titled  "Veterinary Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,"  the  global veterinary molecular diagnostics market size reached US$ 690.8 Million in 2023. Veterinary molecular diagnostics comprise advanced laboratory methods to detect, identify, and genotype various viral, bacterial, and vector-borne pathogens among animals. Some commonly utilized molecular-based techniques include polymerase chain reaction (PCR), in situ hybridization (ISH), nucleic acid sequence-based amplification (NASBA), and proteomics. They aid clinicians in examining the ribonucleic acid (RNA), deoxyribonucleic acid (DNA), or other proteins in animals to diagnose diseases or the predisposition stage. In recent years, veterinary molecular diagnostics have gained immense traction across research laboratories and veterinary health centers since they facilitate rapid and highly accurate detection of nucleic acids and diagnosis of infectious diseases. Request for a PDF sample of this report: https://www.imarcgroup.com/veterinary-molecular-diagnostics-market/requestsample

Report Description Global Veterinary Molecular Diagnostics Market Trends : The surging incidences of zoonotic diseases and the rising animal husbandry activities represent the primary factors driving the market growth. Besides this, the expanding livestock population due to the escalating demand for animal-derived products is another major growth-inducing factor. In addition, there has been widespread adoption of veterinary molecular diagnostics due to growing food safety concerns. Along with this, the increasing pet ownership rates and the emerging pet humanization trend have augmented the product demand owing to the rising awareness about animal health and wellbeing among pet parents. Furthermore, the recent advancements in proteomics and nanotechnology have led to the development of innovative, fully automated, and high throughput systems. In line with this, the surging demand for customized reagents and kits has catalyzed market growth. Moreover, the sudden outbreak of coronavirus disease (COVID-19) has accelerated the adoption of PCR testing to examine the effect of the infection in animals. Other factors, including the launch of advanced genotyping techniques, favorable government initiatives, rising adoption of pet insurance policies, increasing pet healthcare expenditure, development in the animal healthcare sector, and product innovations, are also providing a positive thrust to the market growth. Looking forward, IMARC Group expects the market value to reach US$ 1,391.9 Million by 2032, expanding at a CAGR of 7.9% during the forecast period (2024-2032). View Report TOC, Figures and Tables : https://www.imarcgroup.com/veterinary-molecular-diagnostics-market

Report Segmentation Breakup by Product: Kits and Reagents Instruments Software and Services   Breakup by Technology: Real Time PCR Microarray DNA Sequencing Breakup by Animal Type: Companion Animal Livestock Animal Breakup by Disease Type: Vector-borne Diseases Respiratory Pathogens

Report Segmentation Diarrhea Pathogens Others Breakup by End User: Veterinary Hospitals Clinical Laboratories Research Institutes Breakup by Region: North America Asia-Pacific Europe Latin America Middle East and Africa

Competitive Landscape with Key Players Biochek B.V. bioMérieux SA HealthGene Corporation Heska Corporation IDEXX Laboratories Inc. INDICAL BIOSCIENCE GmbH Ingenetix GmbH NEOGEN Corporation Qiagen N.V Thermo Fisher Scientific Inc. Veterinary Molecular Diagnostics Inc. Zoetis Inc.

Key Questions Answered in the Report

Key Questions Answered in the Report

Table of Contents 1    Preface 2    Scope and Methodology     2.1    Objectives of the Study     2.2    Stakeholders     2.3    Data Sources         2.3.1    Primary Sources         2.3.2    Secondary Sources     2.4    Market Estimation         2.4.1    Bottom-Up Approach         2.4.2    Top-Down Approach     2.5    Forecasting Methodology 3    Executive Summary 4    Introduction     4.1    Overview     4.2    Key Industry Trends 5    Global Veterinary Molecular Diagnostics Market     5.1    Market Overview     5.2    Market Performance     5.3    Impact of COVID-19   5.4    Market Forecast 6     Market Breakup by Product 6.1 Kits and Reagents 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Instruments 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Software and Services 6.3.1 Market Trends 6.3.2 Market Forecast 7 Market Breakup by Technology        

Table of Contents 7.1 Real Time PCR 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Microarray 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 DNA Sequencing 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Animal Type 8.1 Companion Animal 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Livestock Animal 8.2.1 Market Trends 8.2.2 Market Forecast 9 Market Breakup by Disease Type 9.1 Vector-borne Diseases 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Respiratory Pathogens 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Diarrhea Pathogens 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Others 9.4.1 Market Trends 9.4.2 Market Forecast For more information, visit : https://www.imarcgroup.com/veterinary-molecular-diagnostics-market/toc

Disclaimer © 2023 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us Visit us at : https://www.imarcgroup.com TELEPHONE: +1-631-791-1145 E-MAIL: [email protected]
Tags